CO-DEVELOPMENT AND COMMERCIALIZATION AGREEMENTDevelopment and Commercialization Agreement • November 7th, 2008 • Maxygen Inc • Services-commercial physical & biological research • New York
This Co-Development and Commercialization Agreement (this “Agreement”) is entered into as of the 18th day of September, 2008 (“Effective Date”) by and between Astellas Pharma Inc., a Japanese corporation, with its principal place of business at 3-11, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 103-8411 Japan (“Astellas”) and Maxygen, Inc., a Delaware corporation with its principal place of business at 515 Galveston Drive, Redwood City, California, 94063 (“Maxygen”). Astellas and Maxygen are each referred to herein by name or, individually, as a “Party” or, collectively, as the “Parties.”
